✦ LIBER ✦

Biweekly irinotecan (IRI) with 6s-folinic acid (FA)-modulated 5-fluorouracil (FU) i.v. bolus in advanced colorectal carcinoma (ACC): a phase III study

✍ Scribed by Comella, P.; De Vita, F.; De Lucia, L.; Crucitta, E.; Biglietto, M.; Farris, A.; Del Gaizo, F.; Palmeri, S.; Iannelli, A.; Mancarella, S.

Book ID: 122610530
Publisher: Elsevier Science
Year: 2001
Tongue: English
Weight: 160 KB
Volume: 37
Category: Article
ISSN: 0959-8049
DOI: 10.1016/S0959-8049(01)81605-1

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A novel biweekly multidrug regimen of ge

A novel biweekly multidrug regimen of gemcitabine, oxaliplatin, 5-fluorouracil (5-FU), and folinic acid (FA) in pretreated patients with advanced colorectal carcinoma

✍ Correale, P; Messinese, S; Caraglia, M; Marsili, S; Piccolomini, A; Petrioli, R; 📂 Article 📅 2004 🏛 Nature Publishing Group 🌐 English ⚖ 89 KB

Folinic acid (FA) and 5-fluorouracil (FU

Folinic acid (FA) and 5-fluorouracil (FU) alone or with irinotecan (CPT-11) for advanced colorectal cancer (ACC): Preliminary results of a randomized phase II trial

✍ E. Maiello; F. Giuliani; V. Gebbia; S. Cigolari; S. Fortunato; G. Paoletti; N. B 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 110 KB

Phase III trial of bolus 5-fluorouracil

Phase III trial of bolus 5-fluorouracil (5-FU)/folinic acid (FA) (MAYO) vs. weekly oxaliplatin (OXA) plus high dose 24h 5-FU infusion/FA in patients with advanced colorectal cancer (CRC)

✍ A. Grothey; T. Buechele; H. Kroening; K. Ridwelski; P. Reichardt; A. Kretzschmar 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 163 KB

755 - A phase II trial of trimetrexate (

755 - A phase II trial of trimetrexate (TMTX), 5-fluorouracil (5-FU) and folinic acid (FA) in untreated patients with advanced colorectal carcinoma

✍ E.D. Kreuser; H. Szelenyi; P. Hohenberger; H. Lochs; N. Habboubi; W. Oster; E. T 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 260 KB

Irinotecan and chronomodulated infusion

Irinotecan and chronomodulated infusion of 5-fluorouracil and folinic acid in the treatment of patients with advanced colorectal carcinoma : A Phase I study

✍ Carlo Garufi; Luigi Dogliotti; Rita M. D'Attino; Marco Tampellini; Anna M. Asche 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 106 KB 👁 3 views

Cetuximab (C225, Erbitux) in combination

Cetuximab (C225, Erbitux) in combination with irinotecan, infusional 5-fluorouracil (5-FU) and folinic acid (FA) is safe and active in patients (pts) with metastatic colorectal cancer (CRC) expressing epidermal growth factor-receptor (EGFR). Results of a phase I study

📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 306 KB